ROME and MILAN, Oct. 3, 2025 /PRNewswire/ -- The Department of Clinical and Molecular Medicine of Sapienza University of Rome (DMCM), Takis S.r.l. and Tethis S.p.A. today announce a joint initiative, to accelerate research on HER3-targeted therapies and advance the development of...
Hence then, the article about the department of clinical and molecular medicine of sapienza university of rome takis and tethis start a collaboration to advance her3 targeted therapies and diagnostics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Department of Clinical and Molecular Medicine of Sapienza University of Rome, Takis and Tethis start a collaboration to advance HER3-targeted therapies and diagnostics )
Also on site :
- ‘World of Warcraft’ Just Upgraded Its Best City for the First Time in 20 Years, and Now It’s Perfect
- Todd Meadows Cause of Death: What We Know About the 'Deadliest Catch' Star's Death so Far
- ChatGPT uninstalls surged by 295% after DoD deal